Financial PerformanceEvolus reported strong quarterly results, with total sales significantly exceeding market expectations, demonstrating a robust demand for Jeuveau.
Market ExpansionEvolus plans to launch Nuceiva in additional countries, including Australia and Spain, potentially increasing its market presence.
Product ApprovalEvolysse products demonstrated superiority to Restylane at 6 months and improvement in key secondary endpoints, supporting the Premarket Approval application to the FDA.